Search research articles
Contact Us
Filters
Showing results (11-20 of 481) with videos related to
Page
of 49
Sort By:
Alimentary Pharmacology & Therapeutics
|
June 12, 2004
'Guidelines' or marketing for non-steroidal anti-inflammatory drug and proton pump inhibitor use?
David Y Graham
Therapeutic Advances in Gastroenterology
|
October 14, 2021
Comments regarding use of rifabutin for <i>Helicobacter pylori</i> eradication
David Y Graham
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 30, 2009
Endoscopic ulcers are neither meaningful nor validated as a surrogate for clinically significant upper gastrointestinal harm
David Y Graham
Helicobacter
|
March 12, 2002
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users
David Y Graham
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 12, 2013
Helicobacter pylori eradication and metachronous gastric cancer
David Y Graham
Helicobacter
|
November 28, 2015
Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype
David Y Graham
Helicobacter
|
June 17, 2024
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New Editor
David Y Graham
Japanese Journal of Helicobacter Research
|
January 17, 2017
Gastric cancer surveillance or prevention plus targeted surveillance
David Y Graham
Gastroenterology
|
March 1, 2021
Molecular-based Helicobacter pylori Susceptibility Testing Is Almost Ready for Prime Time
David Y Graham
Gastroenterology
|
February 7, 2015
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits
David Y Graham
Page
of 49
Search research articles
Search
Showing results (11-20 of 481) with videos related to
Sort By:
Page
of 49
Alimentary Pharmacology & Therapeutics
|
June 12, 2004
'Guidelines' or marketing for non-steroidal anti-inflammatory drug and proton pump inhibitor use?
David Y Graham
Therapeutic Advances in Gastroenterology
|
October 14, 2021
Comments regarding use of rifabutin for <i>Helicobacter pylori</i> eradication
David Y Graham
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 30, 2009
Endoscopic ulcers are neither meaningful nor validated as a surrogate for clinically significant upper gastrointestinal harm
David Y Graham
Helicobacter
|
March 12, 2002
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users
David Y Graham
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 12, 2013
Helicobacter pylori eradication and metachronous gastric cancer
David Y Graham
Helicobacter
|
November 28, 2015
Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype
David Y Graham
Helicobacter
|
June 17, 2024
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New Editor
David Y Graham
Japanese Journal of Helicobacter Research
|
January 17, 2017
Gastric cancer surveillance or prevention plus targeted surveillance
David Y Graham
Gastroenterology
|
March 1, 2021
Molecular-based Helicobacter pylori Susceptibility Testing Is Almost Ready for Prime Time
David Y Graham
Gastroenterology
|
February 7, 2015
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits
David Y Graham
Page
of 49